WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Thursday, March 22, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email

Global Genitourinary Partnering Deal Trends, Players and Financials 2012-2018: Comprehensive Access to Over 3500 Genitourinary Deal Records
Tuesday, March 13, 2018

Global Genitourinary Partnering Deal Trends, Players and Financials 2012-2018: Comprehensive Access to Over 3500 Genitourinary Deal Records

DUBLIN, March 13, 2018 /PRNewswire/ --

The "Global Genitourinary Partnering 2012-2018: Deal trends, players and financials" report has been added to's offering.

Global Genitourinary Partnering 2012 to 2018 provides the full collection of Genitourinary disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Genitourinary disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Genitourinary deals.

The report presents financial deal terms values for Genitourinary deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Genitourinary partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Genitourinary technologies and products.

Report scope

Global Genitourinary Partnering 2012 to 2018 is intended to provide the reader with an in-depth understanding and access to Genitourinary trends and structure of deals entered into by leading companies worldwide.

Global Genitourinary Partnering 2012 to 2018 includes:

    --  Trends in Genitourinary dealmaking in the biopharma industry since 2012
    --  Analysis of Genitourinary deal structure
    --  Access to headline, upfront, milestone and royalty data
    --  Access to hundreds of Genitourinary deal contract documents
    --  Comprehensive access to over 3500 Genitourinary deal records
    --  The leading Genitourinary deals by value since 2012
    --  Most active Genitourinary dealmakers since 2012

The report includes deals for the following indications: Discharge, Frequency, Incontinence, Itching, Nocturia, Urgency, Acute kidney injury, Amyloidosis, Chronic kidney disease (CKD), Cystitis, Diabetic nephropathy, Dialysis, Hemolytic-uremic syndrome (HUS), Kidney stones, Nephrotic syndrom, Overactive bladder, Peyronie's disease, Polycystic kidney disease, Prostate diseases, Prostatitis, Prostate enlargement, Renal failure, Renal infections, Nephritis, Glomerulonephritis, Pyelonephritis, Vesicoureteral reflux, Urinary tract infection (UTI), plus other genitourinary indications.

In Global Genitourinary Partnering 2012 to 2018, available deals and contracts are listed by:

    --  Headline value
    --  Upfront payment value
    --  Royalty rate value
    --  Stage of development at signing
    --  Deal component type
    --  Technology type
    --  Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Genitourinary Partnering 2012 to 2018 report provides comprehensive access to available deals and contract documents for over 3500 Genitourinary deals. Analyzing actual contract agreements allows assessment of the following:

    --  What are the precise Genitourinary rights granted or optioned?
    --  What is actually granted by the agreement to the partner company?
    --  What exclusivity is granted?
    --  What is the payment structure for the deal?
    --  How aresalesand payments audited?
    --  What is the deal term?
    --  How are the key terms of the agreement defined?
    --  How are IPRs handled and owned?
    --  Who is responsible for commercialization?
    --  Who is responsible for development, supply, and manufacture?
    --  How is confidentiality and publication managed?
    --  How are disputes to be resolved?
    --  Under what conditions can the deal be terminated?
    --  What happens when there is a change of ownership?
    --  What sublicensing and subcontracting provisions have been agreed?
    --  Which boilerplate clauses does the company insist upon?
    --  Which boilerplate clauses appear to differ from partner to partner or
        deal type to deal type?

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Cobra Electronics Announces 'Race to the Final' Sweepstakes with NASCAR Driver Bubba Wallace | Mar 22, 2018
Nav Orexo Publishes the Annual Report for 2017 | Mar 22, 2018
Nav Confidex Announces the Launch of MYVIA by Confidex(TM) - The Platform for Airports With Passion for Customer Experience | Mar 22, 2018
Nav The Raw Word Gets Raw With Author Of "What To Do When Jane Knows DICK About Dating" (Video) | Mar 22, 2018
Nav Clean Named Agency Of Record For North Carolina Zoo And Aquariums | Mar 22, 2018
Nav 2018 Global Postpartum Hemorrhage (PPH) Devices Market Analysis & Trends - Industry Forecast to 2027 | Mar 22, 2018
Nav Software Asset Management Market to Grow at 14.8% CAGR to 2022 | Mar 22, 2018
Nav Keith Jacobs and Craig Penk Join Gateway Architects' Advisory Board | Mar 22, 2018
Nav ANSYS to Acquire Optical Simulation Leader OPTIS | Mar 22, 2018
Nav Pre-Market Technical Scan on REIT Equities -- GGP Inc., Kimco Realty, Pennsylvania REIT, and Regency Centers | Mar 22, 2018

Submit News | View More News View More News